Newsfiscal.ai
Niki BioSolutions Subsidiary DiamiR Biosciences Signs APOE Genotyping Agreement with Charter Research
· Published
Article summary
Niki BioSolutions, Inc. announced that its subsidiary, DiamiR Biosciences, has entered into an agreement to provide apolipoprotein E (APOE) genotyping services for Charter Research.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…